A High-Affinity Cu-64-Labeled Ligand for PET Imaging of Hepsin: Design, Synthesis, and Characterization
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Ji-Hun | - |
dc.contributor.author | Zhang, Xuran | - |
dc.contributor.author | Ha, Hyunsoo | - |
dc.contributor.author | Kim, Jung | - |
dc.contributor.author | Choi, Joon | - |
dc.contributor.author | Lee, Kyung-Han | - |
dc.contributor.author | Byun, Youngjoo | - |
dc.contributor.author | Choe, Yearn | - |
dc.date.accessioned | 2022-11-18T15:40:38Z | - |
dc.date.available | 2022-11-18T15:40:38Z | - |
dc.date.created | 2022-11-17 | - |
dc.date.issued | 2022-09 | - |
dc.identifier.issn | 1424-8247 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/145772 | - |
dc.description.abstract | Hepsin, a cell surface serine protease, is a potential biomarker for the detection of prostate cancer due to its high expression in prostate cancer but not in normal prostate. This study aimed to develop a radioligand for positron emission tomography (PET) imaging of hepsin. Six leucine-arginine (Leu-Arg) dipeptide derivatives (two diastereomers for each of three ligands) were synthesized and evaluated for their binding affinities and selectivity for hepsin. Based on the binding assay, a Cu-nat-1,4,7,10-tetraazacyclododecane-N,N',N '' N'''-tetraacetic acid (DOTA)-conjugated ligand (3B) was selected for the development of a PET radioligand. [Cu-64]3B was synthesized by labeling the DOTA-conjugated compound 11B with [Cu-64]CuCl2 at 80 degrees C for 20 min. The radioligand was evaluated for prostate cancer cell binding and PET imaging in a prostate tumor mouse model. The results demonstrated that [Cu-64]3B exhibited high binding to LNCaP cells, intermediate binding to 22Rv1 cells, and low binding to PC3 cells. PET studies of [Cu-64]3B in mice, implanted with 22Rv1 and PC3 cells on each flank, revealed that the radioligand uptake was high and persistent in the 22Rv1 tumors over time, whereas it was low in PC3 tumors. The results of this study suggest that [Cu-64]3B is a promising PET radioligand for hepsin imaging. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.subject | PROSTATE-SPECIFIC ANTIGEN | - |
dc.subject | BIOLOGICAL EVALUATION | - |
dc.subject | CANCER STATISTICS | - |
dc.subject | INHIBITORS | - |
dc.subject | DISCOVERY | - |
dc.subject | REVEALS | - |
dc.subject | POTENT | - |
dc.subject | HGFA | - |
dc.title | A High-Affinity Cu-64-Labeled Ligand for PET Imaging of Hepsin: Design, Synthesis, and Characterization | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Byun, Youngjoo | - |
dc.identifier.doi | 10.3390/ph15091109 | - |
dc.identifier.scopusid | 2-s2.0-85138662682 | - |
dc.identifier.wosid | 000859497900001 | - |
dc.identifier.bibliographicCitation | PHARMACEUTICALS, v.15, no.9 | - |
dc.relation.isPartOf | PHARMACEUTICALS | - |
dc.citation.title | PHARMACEUTICALS | - |
dc.citation.volume | 15 | - |
dc.citation.number | 9 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | PROSTATE-SPECIFIC ANTIGEN | - |
dc.subject.keywordPlus | BIOLOGICAL EVALUATION | - |
dc.subject.keywordPlus | CANCER STATISTICS | - |
dc.subject.keywordPlus | INHIBITORS | - |
dc.subject.keywordPlus | DISCOVERY | - |
dc.subject.keywordPlus | REVEALS | - |
dc.subject.keywordPlus | POTENT | - |
dc.subject.keywordPlus | HGFA | - |
dc.subject.keywordAuthor | hepsin | - |
dc.subject.keywordAuthor | prostate cancer | - |
dc.subject.keywordAuthor | Cu-64-DOTA-conjugated ligand | - |
dc.subject.keywordAuthor | Leu-Arg dipeptide derivatives | - |
dc.subject.keywordAuthor | diastereomers | - |
dc.subject.keywordAuthor | PET | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.